MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors

Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal Cancer

(2011) A. N. Bartley et al.   CLINICAL CANCER RESEARCH

A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

(2011) Trupti Paranjape et al.   LANCET ONCOLOGY

Cystic precursors to invasive pancreatic cancer

(2011) Hanno Matthaei et al.   Nature Reviews Gastroenterology & Hepatology

miR-126 and miR-126*: New Players in Cancer

(2011) Jeannette Meister et al.   TheScientificWorldJOURNAL

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

(2010) Nils Habbe et al.   CANCER BIOLOGY & THERAPY

miR-126 functions as a tumour suppressor in human gastric cancer

(2010) Runhua Feng et al.   CANCER LETTERS

miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer

(2010) S. Yu et al.   CANCER RESEARCH

The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS

(2010) Wu-Gan Zhao et al.   CARCINOGENESIS

MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions

(2010) M. C. du Rieu et al.   CLINICAL CHEMISTRY

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

(2010) O. A. Kent et al.   GENES & DEVELOPMENT

MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation

(2010) Jun Yu et al.   Molecular Cancer

HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells

(2009) Sugiko Watanabe et al.   AMERICAN JOURNAL OF PATHOLOGY

miR-21as a key regulator of oncogenic processes

(2009) S. Duygu Selcuklu et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments

(2009) Andreas Keller et al.   BMC CANCER

A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival

(2009) Anurag Singh et al.   CANCER CELL

Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras

(2009) Sharon Y. Gidekel Friedlander et al.   CANCER CELL

MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer

(2009) R. Bhattacharya et al.   CANCER RESEARCH

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

(2009) R I Aqeilan et al.   CELL DEATH AND DIFFERENTIATION

Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics

(2009) Stefano Crippa et al.   Clinical Gastroenterology and Hepatology

let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression

(2009) Jérôme Torrisani et al.   HUMAN GENE THERAPY

Lin28-let7 Modulates Radiosensitivity of Human Cancer Cells With Activation of K-Ras

(2009) Jee-Sun Oh et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-Cycle Genes via Binding to “Seedless” 3′UTR MicroRNA Recognition Elements

(2009) Ashish Lal et al.   MOLECULAR CELL

Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes

(2009) Fumitaka Takeshita et al.   MOLECULAR THERAPY

An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression

(2009) Jay S Desgrosellier et al.   NATURE MEDICINE

Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration

(2009) X Li et al.   ONCOGENE

Role of miR-143 targeting KRAS in colorectal tumorigenesis

(2009) X Chen et al.   ONCOGENE

The estrogen receptor- -induced microRNA signature regulates itself and its transcriptional response

(2009) L. Castellano et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cystic Pancreatic Lesions: Classification and Management

(2009) Dushyant V. Sahani et al.   Journal of the American College of Radiology

MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines

(2008) M. Crawford et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Analysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues

(2008) A. E. Szafranska et al.   CLINICAL CHEMISTRY

Pancreatic Cancer within a UK Cancer Network with Special Emphasis on Locally Advanced Non-metastatic Pancreatic Cancer

(2008) S. Mukherjee et al.   CLINICAL ONCOLOGY

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

(2008) Lin Xia et al.   INTERNATIONAL JOURNAL OF CANCER

miR-21: a small multi-faceted RNA

(2008) Anna M. Krichevsky et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival

(2008) Mary Dillhoff et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Endogenous human microRNAs that suppress breast cancer metastasis

(2008) Sohail F. Tavazoie et al.   NATURE

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

(2008) Désirée Bonci et al.   NATURE MEDICINE

Microfluidic-based enzymatic on-chip labeling of miRNAs

(2008) Sonja Vorwerk et al.   New Biotechnology

Cystic Lesions of the Pancreas

(2008) G. Garcea et al.   PANCREATOLOGY

MicroRNAs in Pancreatic Ductal Adenocarcinoma: New Diagnostic and Therapeutic Clues

(2008) Mylene Seux et al.   PANCREATOLOGY